Quick Answer
CYTOKINETICS INC reported Revenue From Contract With Customer Excluding Assessed Tax of $88.04 million for the year ending 2025.
- CYTOKINETICS INC showed an increase of +376.6% in Revenue From Contract With Customer Excluding Assessed Tax from 2024 to 2025.
- This data is from CYTOKINETICS INC's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2018: $5.27 million | Q2 2018: $6.22 million | Q3 2018: $10.64 million | Q1 2019: $8.46 million | Q2 2019: $7.14 million | Q3 2019: $6.06 million | Q1 2020: $3.83 million | Q2 2020: $3.59 million | Q3 2020: $41.69 million | Q1 2021: $6.55 million | Q2 2021: $2.84 million | Q3 2021: $5.44 million | Q1 2022: $1.15 million | Q2 2022: $88.97 million | Q3 2022: $2.52 million | Q1 2023: $4.61 million | Q2 2023: $867.0 thousand | Q3 2023: $378.0 thousand | Q1 2024: $835.0 thousand | Q2 2024: $249.0 thousand | Q3 2024: $463.0 thousand | Q1 2025: $1.58 million | Q2 2025: $66.77 million | Q3 2025: $1.94 million.
- Over the full 9 years of available data (2017 to 2025), CYTOKINETICS INC's Revenue From Contract With Customer Excluding Assessed Tax has grown by 558.6%.
- Historical annual values: Fiscal year 2025: $88.04 million | Fiscal year 2024: $18.47 million | Fiscal year 2023: $7.53 million | Fiscal year 2022: $94.59 million | Fiscal year 2021: $70.43 million | Fiscal year 2020: $55.83 million | Fiscal year 2019: $26.87 million | Fiscal year 2018: $31.50 million | Fiscal year 2017: $13.37 million.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: